Literature DB >> 5573769

Methotrexate tissue distribution: prediction by a mathematical model.

D S Zaharko, R L Dedrick, K B Bischoff, J A Longstreth, V T Oliverio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5573769

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  A pharmacokinetic model for high-dose methotrexate infusions in man.

Authors:  S D Reich; N R Bachur; R H Goebel; M Berman
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

Review 2.  Physiologically based pharmacokinetic models for anticancer drugs.

Authors:  H S Chen; J F Gross
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.

Authors:  W E Evans; C B Pratt; R H Taylor; L F Barker; W R Crom
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Pharmacological vs. classical approaches in the design of first in man clinical drug trials.

Authors:  Cornelis A van den Bogert; Adam F Cohen; Hubert G M Leufkens; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2017-10-06       Impact factor: 4.335

5.  A physiologically based pharmacokinetic model of mitoxantrone in mice and scale-up to humans: a semi-mechanistic model incorporating DNA and protein binding.

Authors:  Guohua An; Marilyn E Morris
Journal:  AAPS J       Date:  2012-03-27       Impact factor: 4.009

6.  Incorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice.

Authors:  Susan F Hudachek; Daniel L Gustafson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-25       Impact factor: 2.745

7.  Mathematical modeling -- guide to high-dose methotrexate infusion therapy.

Authors:  S D Reich
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 8.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

9.  A minimal physiologically based pharmacokinetic model for high-dose methotrexate.

Authors:  Giuseppe Pesenti; Marco Foppoli; Davide Manca
Journal:  Cancer Chemother Pharmacol       Date:  2021-06-13       Impact factor: 3.333
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.